Arvinas
Latest round
- Series C
Last raised
- Mar 2018
Total raised
- $100M
Investors
- 11
About Arvinas
Founded in 2013 and based in Connecticut, US, Arvinas, Inc. is a biopharmaceutical company that develops protein degradation therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases.
Who invested in Arvinas
11 investors across 3 rounds
See all investors in Arvinas
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Arvinas
Who invested in Arvinas?
Arvinas has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arvinas raised?
Arvinas has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Arvinas last raise money?
Arvinas's most recent round on record is a Series C, in Mar 2018.
What does Arvinas do?
Founded in 2013 and based in Connecticut, US, Arvinas, Inc.
Where is Arvinas headquartered?
Arvinas is headquartered in New Haven, US.
Which VCs invest in companies like Arvinas?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Arvinas's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Arvinas? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.